Balanced news tone
News Sentiment
SILO sentiment intelligence
Silo Pharma Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
37 relevant articles
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-7.8% over one week, -14.0% over four weeks, trend active, and below fair value.
Silo Pharma (SILO) completes $4,000,015 private exempt securities sale
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
86/100 classification
One-week reaction
-7.8%
Price reacting lower
Trend fit
Trend active
-14.0% over four weeks
Fair value
-65.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
28
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stock Titan
Direct company coverage
Silo Pharma (SILO) completes $4,000,015 private exempt securities sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 18:08
- Source
- Stock Titan
Investing.com Nigeria
Direct company coverage
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Jul 2026 13:12
- Source
- Investing.com Nigeria
Market source
Direct company coverage
Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jul 2026 09:22
- Source
- Market source
Benzinga
Direct company coverage
Why Is Silo Pharma Stock Volatile Today? - SILO Pharma (NASDAQ:SILO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 15:45
- Source
- Benzinga
InvestorsHub
Direct company coverage
Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 14:42
- Source
- InvestorsHub
Quiver Quantitative
Direct company coverage
Silo Pharma’s QwikAgents Accepted Into AMD AI Developer Program
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 13:01
- Source
- Quiver Quantitative
GlobeNewswire
Direct company coverage
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 12:55
- Source
- GlobeNewswire
Kalkine
Direct company coverage
Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:00
- Source
- Kalkine
Market source
Industry context
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
TradingView
Direct company coverage
Silo Pharma Raises Approximately $3.5 Million Net in Private Placement; Grants Resale Rights
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 10:23
- Source
- TradingView
TradingView
Direct company coverage
Price to sales forward of Silo Pharma, Inc. – NASDAQ:SILO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 22:54
- Source
- TradingView
Market source
Direct company coverage
Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 14:03
- Source
- Market source
Baystreet.ca
Direct company coverage
Silo Pharma Sinks on Stock Sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 13:56
- Source
- Baystreet.ca
Investing.com
Direct company coverage
Silo Pharma raises $4 million in private placement
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 13:04
- Source
- Investing.com
MT Newswires
Direct company coverage
Silo Pharma Launches Private Placement to Raise Up to $11.7 Million
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 10 Jul 2026 12:39
- Source
- MT Newswires
Quiver Quantitative
Direct company coverage
Silo Pharma Announces $4 Million Private Placement with Up to Approximately $7.7 Million in Potential Additional Gross Proceeds from Warrants
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:13
- Source
- Quiver Quantitative
Investing.com
Direct company coverage
Silo Pharma stock tumbles 22% on dilutive private placement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:11
- Source
- Investing.com
GlobeNewswire
Direct company coverage
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:00
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Biotech Silo Pharma lines up $11.7M in stock and warrant funding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
AdvisorShares Trust (NASDAQ: SILO) holds 6.69% of Silo Pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 21:23
- Source
- Stock Titan
Stock Titan
Direct company coverage
Silo Pharma (SILO) sets 2026 meeting on directors, auditor and stock increase
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Silo Pharma tests nasal spray device for PTSD drug ahead of FDA meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stock Titan
MT Newswires
Direct company coverage
Silo Pharma Says SPC-15 PTSD Nasal Spray Remains Stable for 9 Months
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 12:55
- Source
- MT Newswires
Stock Titan
Direct company coverage
Silo Pharma's PTSD spray clears 9 months of stability testing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Silo Pharma (SILO) completes 1-for-15 reverse stock split and cuts authorized shares
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Stock Titan
Investing.com
Direct company coverage
Silo Pharma announces 1-for-15 reverse stock split effective June 2
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Investing.com
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source